Literature DB >> 35758317

Estimated wasteful spending on aducanumab dispensing in the U.S. Medicare population: A cross-sectional analysis.

Carlos Irwin A Oronce1,2, Julia Cave Arbanas1, Mei Leng1, Bruce E Landon3,4, Cheryl L Damberg5, Catherine Sarkisian1,2, John N Mafi1,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35758317      PMCID： PMC9489619          DOI： 10.1111/jgs.17891

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   7.538


× No keyword cloud information.
  4 in total

1.  National estimates of the quantity and cost of informal caregiving for the elderly with dementia.

Authors:  K M Langa; M E Chernew; M U Kabeto; A R Herzog; M B Ofstedal; R J Willis; R B Wallace; L M Mucha; W L Straus; A M Fendrick
Journal:  J Gen Intern Med       Date:  2001-11       Impact factor: 5.128

2.  Estimated Annual Spending on Aducanumab in the US Medicare Program.

Authors:  John N Mafi; Mei Leng; Julia Cave Arbanas; Chi-Hong Tseng; Cheryl L Damberg; Catherine Sarkisian; Bruce E Landon
Journal:  JAMA Health Forum       Date:  2022-01-14

3.  Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.

Authors:  P M Doraiswamy; R A Sperling; K Johnson; E M Reiman; T Z Wong; M N Sabbagh; C H Sadowsky; A S Fleisher; A Carpenter; A D Joshi; M Lu; M Grundman; M A Mintun; D M Skovronsky; M J Pontecorvo
Journal:  Mol Psychiatry       Date:  2014-03-11       Impact factor: 15.992

4.  Alzheimer's disease drug development pipeline: 2021.

Authors:  Jeffrey Cummings; Garam Lee; Kate Zhong; Jorge Fonseca; Kazem Taghva
Journal:  Alzheimers Dement (N Y)       Date:  2021-05-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.